IL-33 broadens its repertoire to affect DC

European Journal of Immunology

Volumn 39, Issue 12, 2009, Pages 3292-3295

  Turnquist, Heth R ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Basophils; DC; GM CSF; IL 33; ST2L (IL 1 receptor like 1)

Indexed keywords

CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; BASOPHIL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENTERITIS; HUMAN; INNATE IMMUNITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; ANTIGENS, CD11C; BONE MARROW CELLS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKINS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73249124755     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940026     Document Type: Note

References (33)

1. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
2. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. et al., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007. 104: 282-287.
3. Baekkevold, E. S., Roussigne, M., Yamanaka, T., Johansen, F. E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P. et al., Molecular characterization of NFHEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 2003. 163: 69-79.
4. Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H. et al., IL-33 reduces the development of atherosclerosis. J. Exp. Med. 2008. 205: 339-346.
5. Haraldsen, G., Balogh, J., Pollheimer, J., Sponheim, J. and Küchler, A. M., Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol. 2009. 30: 227-233.
6. Talabot-Ayer, D., Lamacchia, C., Gabay, C. and Palmer, G., Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 2009. 284: 19420-19426.
7. Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G. et al., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009. 31: 84-98.
8. Hayakawa, M., Hayakawa, H., Matsuyama, Y., Tamemoto, H., Okazaki, H. and Tominaga, S., Mature interleukin-33 is produced by calpainmediated cleavage in vivo. Biochem. Biophys. Res. Commun. 2009. 387: 218-222.
9. Arend, W. P., Palmer, G. and Gabay, C., IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008. 223: 20-38.
10. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S. and Kastelein, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 2551-2555.
11. Ali, S., Huber, M., Kollewe, C., Bischoff, S. C., Falk, W. and Martin, M. U., IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 2007. 104: 18660-18665.
12. Xu, D., Chan, W. L., Leung, B. P., Huang, F., Wheeler, R., Piedrafita, D., Robinson, J. H. et al., Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 1998. 187: 787-794.
13. Moritz, D. R., Rodewald, H. R., Gheyselinck, J. and Klemenz, R., The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 1998. 161: 4866-4874.
14. Lohning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J. C., Levinson, D. et al., T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 1998. 95: 6930-6935.
15. O'Neill, L. A. and Dinarello, C. A., The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 2000. 21: 206-209.
16. Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P. et al., Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 1999. 190: 895-902.
17. Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E. and McKenzie, A. N., T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 2000. 191: 1069-1076.
18. Pecaric-Petkovic, T., Didichenko, S. A., Kaempfer, S., Spiegl, N. and Dahinden, C. A., Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009. 113: 1526-1534.
19. Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y. et al., IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J. Immunol. 2008. 181: 62-72.
20. Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L. and Kita, H., IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 2009. 123: 1047-1054.
21. Suzukawa, M., Iikura, M., Koketsu, R., Nagase, H., Tamura, C., Komiya, A., Nakae, S. et al., An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 2008. 181: 5981-5989.
22. Suzukawa, M., Koketsu, R., Iikura, M., Nakae, S., Matsumoto, K., Nagase, H., Saito, H. et al., Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab. Invest. 2008. 88: 1245-1253.
23. Brint, E. K., Xu, D., Liu, H., Dunne, A., McKenzie, A. N., O'Neill, L. A. and Liew, F. Y., ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 2004. 5: 373-379.
24. Espinassous, Q., Garcia-de-Paco, E., Garcia-Verdugo, I., Synguelakis, M., von Aulock, S., Sallenave, J. M., McKenzie, A. N. et al., IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 2009. 183: 1446-1455.
25. Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N. et al., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 2008. 105: 10913-10918.
26. Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M. et al., IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 2008. 181: 4780-4790.
27. Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. et al., The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 2009. 106: 9773-9778.
28. Hayakawa, H., Hayakawa, M., Kume, A. and Tominaga, S. I., Soluble ST2 blocks IL-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007. 282: 26369-26380.
29. Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. and Lee, R. T., IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 2007. 117: 1538-1549.
30. Schneider, E., Petit-Bertron, A. F., Bricard, R., Levasseur, M., Ramadan, A., Girard, J. P., Herbelin, A. et al., IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J. Immunol. 2009. 183: 3591-3597.
31. Mayuzumi, N., Matsushima, H. and Takashima, A., IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur. J. Immunol. 2009 39: 3331-3342.
32. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
33. Smithgall, M. D., Comeau, M. R., Yoon, B. R., Kaufman, D., Armitage, R. and Smith, D. E., IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 2008. 20: 1019-1030.